Stockscreener 앱 받기
2.41
1.69%
0.04
Neuraxis Inc 주식(NRXS)의 최신 뉴스
Real time breakdown of NeurAxis Inc. stock performance2025 Year in Review & Momentum Based Trading Ideas - Newser
Is NeurAxis Inc. meeting your algorithmic filter criteriaBuy Signal & Verified Short-Term Plans - Newser
Real time social sentiment graph for NeurAxis Inc.2025 Major Catalysts & Real-Time Volume Spike Alerts - Newser
Volatility clustering patterns for NeurAxis Inc.July 2025 Outlook & Long Hold Capital Preservation Plans - Newser
Will breakout in NeurAxis Inc. lead to full recoveryBuy Signal & Momentum Based Trading Ideas - Newser
Chart based exit strategy for NeurAxis Inc.Portfolio Risk Summary & Breakout Confirmation Alerts - Newser
Using Bollinger Bands to evaluate NeurAxis Inc.Quarterly Profit Report & Advanced Swing Trade Entry Alerts - Newser
Will NeurAxis Inc. outperform the marketWeekly Investment Report & Weekly Watchlist of Top Performers - Newser
NeurAxis Inc. stock prediction for this weekJuly 2025 PreEarnings & Verified Momentum Stock Watchlist - Newser
Is NeurAxis Inc. forming a bottoming baseEarnings Trend Report & Daily Oversold Stock Bounce Ideas - Newser
What earnings revisions data tells us about NeurAxis Inc.July 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - Newser
Is NeurAxis Inc. Stock a Smart Buy in 2025 Investment Analysis Inside2025 Earnings Impact & Community Driven Trade Alerts - Newser
Is NeurAxis Inc. showing signs of accumulationGlobal Markets & Weekly Momentum Stock Picks - Newser
Neuraxis reports Q2 EPS (22c) vs. (42c) last year - MSN
What moving averages say about NeurAxis Inc.Weekly Trend Summary & Risk Managed Investment Strategies - Newser
How NeurAxis Inc. stock performs during market volatilityWeekly Profit Analysis & Weekly Chart Analysis and Trade Guides - Newser
Sector ETF performance correlation with NeurAxis Inc.Market Sentiment Review & Stock Portfolio Risk Management - Newser
Head to Head Review: Trimedyne (OTCMKTS:TMED) and NeurAxis (NASDAQ:NRXS) - Defense World
Visual analytics tools that track NeurAxis Inc. performanceNew Guidance & Real-Time Market Trend Scan - Newser
Chart based analysis of NeurAxis Inc. trendsJuly 2025 Outlook & Scalable Portfolio Growth Methods - Newser
Using Python tools to backtest NeurAxis Inc. strategies2025 Valuation Update & AI Based Buy and Sell Signals - Newser
Historical volatility pattern of NeurAxis Inc. visualizedShare Buyback & Low Drawdown Momentum Ideas - Newser
NeurAxis, Inc. Reports Robust Q2 2025 Growth - TipRanks
NeurAxis Q2 2025: Unpacking Contradictions in Sales Strategy, Reimbursement, and Revenue Growth - AInvest
Transcript : NeurAxis, Inc., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
NeurAxis Q2 2025 Earnings Call Transcript: Key Highlights - AInvest
Earnings call transcript: Neuraxis Q2 2025 sees 46% revenue growth By Investing.com - Investing.com UK
Earnings call transcript: Neuraxis Q2 2025 sees 46% revenue growth - Investing.com
NeurAxis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
NeurAxis: A High-Growth Medical Tech Play with Clear Path to Profitability and Market Expansion - AInvest
NeurAxis Q2 2025 Earnings: A Catalyst for Neuromodulation Growth in Pediatric and Adult Functional Gastrointestinal Disorders - AInvest
NeurAxis Reports Strong Second Quarter 2025 Financial Results Driven by a 46% Growth in Revenues - GlobeNewswire
NeurAxis Q2 rev up 46% YoY to $894,000. - AInvest
Why NeurAxis Inc. stock attracts strong analyst attentionBest Stocks for 3x Return - newsyoung.net
Is NeurAxis Inc. stock a growth or value playFree Verified Signal From Chart Patterns - Newser
0.41%
0.88%
자본화:
|
볼륨(24시간):